Quality of sleep in children with enuresis and daytime urinary incontinence

• Conditions: F98.0; N39.4; Nonorganic enuresis; Other specified urinary incontinence

• Registration Number: DRKS00015110
• Lead Sponsor: Klinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik am Universitätsklinikum des Saarlandes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Experimental group: children and adolescents aged 5-18 years with one of the following diagnoses: F98.0 (nocturnal enuresis), N39.4 (daytime urinary incontinence).
Control group: typically developed, mentally healthy children and adolescents aged 5-18 years.

Exclusion Criteria

Severe somatic diseases, diseases with severe implications on the quality of sleep (e.g. astma, Diabetes mellitus), mental retardation (IQ <70), encopresis (F98.1)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) Sleep latency<br>2) Sleep duration <br>3) Sleep quality <br><br>Operationalization: Actigraphy measurement over 4 days and 4 nights. Sleep data is evaluated using a specific child algorithm.

Secondary Outcome Measures

Name	Time	Method
1) comorbid psychiatric disorders (CBCL, Kinder-DIPS)<br>2) incontinence assessment (48 hour - micturation protocol, incontinence questionnaire)<br>3) pediatric-internistic and -neurologic status<br>4) intelligence test (HAWIK-IV or RIST)<br><br>Data is assessed once at the beginning of the study assessment.